Merck (MRK) Prepaid Assets (2009 - 2026)
Merck (MRK) posted quarterly Prepaid Assets of $10.6 billion for Q1 2026, up 14.37% year-over-year from $9.3 billion in Q1 2025, and up 1.01% quarter-over-quarter from $10.5 billion in Q4 2025.
Merck (MRK) Prepaid Assets (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Prepaid Assets for 16 consecutive years, with $10.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 14.37% year-over-year to $10.6 billion; the TTM figure through Mar 2026 stood at $10.6 billion (up 14.37% YoY), while the FY2025 annual figure was $10.5 billion, up 20.81% from the prior year.
- Prepaid Assets climbed to $10.6 billion in Q1 2026 per MRK's latest filing, from $10.5 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $10.8 billion in Q3 2025 and bottomed at $6.7 billion in Q3 2023.
- Historically, Prepaid Assets has averaged $8.9 billion across 5 years, with a median of $8.7 billion in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets advanced 2.6% — and 2025, when it jumped 32.37%.
- Merck's Prepaid Assets stood at $7.2 billion in 2022, then gained by 16.72% to $8.4 billion in 2023, then gained by 4.04% to $8.7 billion in 2024, then rose by 20.81% to $10.5 billion in 2025, then increased by 1.01% to $10.6 billion in 2026.
- Business Quant data shows MRK's Prepaid Assets at $10.6 billion in Q1 2026, $10.5 billion in Q4 2025, and $10.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.77 Bn |
| Mar 31, 2026 | 10.62 Bn |
| Dec 31, 2025 | 10.52 Bn |
| Sep 30, 2025 | 10.78 Bn |
| Jun 30, 2025 | 10.00 Bn |
| Mar 31, 2025 | 9.29 Bn |
| Dec 31, 2024 | 8.71 Bn |
| Sep 30, 2024 | 8.14 Bn |
| Jun 30, 2024 | 8.74 Bn |
| Mar 31, 2024 | 7.95 Bn |
| Dec 31, 2023 | 8.37 Bn |
| Sep 30, 2023 | 6.66 Bn |
| Dec 31, 2022 | 7.17 Bn |
| Dec 31, 2021 | 6.99 Bn |
| Dec 31, 2020 | 4.67 Bn |
| Dec 31, 2019 | 4.28 Bn |
| Dec 31, 2018 | 4.50 Bn |
| Dec 31, 2017 | 4.30 Bn |
| Dec 31, 2016 | 4.39 Bn |
| Dec 31, 2015 | 5.14 Bn |